An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...

Researchers from the University of Maryland School of Medicine (UMSOM) and the University of Alabama at Birmingham’s Heersink ...

Pneumonia is a disease that burdens the health care system with more than 1.2 million emergency room visits each year and ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current ...

While there are several bacteria and viruses causing pneumonia, the research team looked specifically at Streptococcus pneumoniae.

Pneumonia is a disease that burdens the healthcare system with more that 1.2 million emergency room visits each year and more ...

Figure 1. ANKLE1 senses mechanical tension in DNA and helps resolve DNA bridges connecting separating daughter nuclei. ANKLE1 ...

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, ...